{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T07:08:23Z","timestamp":1778483303734,"version":"3.51.4"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lynch syndrome is an autosomal dominant cancer predisposition syndrome and the most common cause of hereditary colorectal cancer. In addition to colorectal cancer, it confers substantially increased risks for several extracolonic malignancies. While there is broad consensus regarding the effectiveness of endoscopic colorectal surveillance, recommendations for surveillance of gastric, small bowel, and pancreatic cancers vary considerably among guidelines issued by leading professional societies. These discrepancies largely reflect the limited availability of robust, high-quality evidence. In this narrative review, we summarize the cancer risks for gastric, small bowel, and pancreatic malignancies in Lynch syndrome carriers, discuss recent studies evaluating the outcomes of surveillance strategies, and provide an overview of current guideline recommendations. Furthermore, we highlight emerging approaches that may enhance surveillance strategies in the future. In recent years, increasing research efforts have focused on surveillance for less frequent Lynch syndrome-associated malignancies, however, prospective data from large, well-characterized cohorts remain scarce. Such data are essential to harmonize existing guidelines and to enable the development of personalized surveillance strategies for individuals affected by Lynch syndrome.<\/jats:p>","DOI":"10.1007\/s10689-026-00567-y","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:16:55Z","timestamp":1778480215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimal upper gastrointestinal surveillance strategies for gastric, small bowel and pancreatic cancer detection in Lynch syndrome"],"prefix":"10.1007","volume":"25","author":[{"given":"Tim","family":"Marwitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander M.","family":"Bogdanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"H\u00fcneburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique E.","family":"van Leerdam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"567_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41436","volume":"22","author":"M Dominguez-Valentin","year":"2020","unstructured":"Dominguez-Valentin M, Sampson JR, Sepp\u00e4l\u00e4 TT et al (2020) Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the prospective Lynch syndrome database. Genet Med 22:15\u201325. https:\/\/doi.org\/10.1038\/s41436","journal-title":"Genet Med"},{"key":"567_CR2","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","volume":"67","author":"P M\u00f8ller","year":"2018","unstructured":"M\u00f8ller P, Sepp\u00e4l\u00e4 TT, Bernstein I et al (2018) Cancer risk and survival in path-MMR carriers by gene and gender up to 75 years of age: a report from the prospective Lynch syndrome database. Gut 67:1306\u20131316. https:\/\/doi.org\/10.1136\/gutjnl-2017-314057","journal-title":"Gut"},{"key":"567_CR3","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1200\/JCO.2012.43.2278","volume":"30","author":"C Engel","year":"2012","unstructured":"Engel C, Loeffler M, Steinke V et al (2012) Risks of less common cancers in proven mutation carriers with Lynch syndrome. J Clin Oncol 30:4409\u20134415. https:\/\/doi.org\/10.1200\/JCO.2012.43.2278","journal-title":"J Clin Oncol"},{"key":"567_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/J.1399-0004.2008.01125.X","volume":"75","author":"E Barrow","year":"2009","unstructured":"Barrow E, Robinson L, Alduaij W et al (2009) Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 75:141\u2013149. https:\/\/doi.org\/10.1111\/J.1399-0004.2008.01125.X","journal-title":"Clin Genet"},{"key":"567_CR5","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/j.gastro.2004.12.051","volume":"128","author":"K Schulmann","year":"2005","unstructured":"Schulmann K, Brasch FE, Kunstmann E et al (2005) HNPCC-associated small bowel cancer: clinical and molecular characteristics. Gastroenterology 128:590\u2013599. https:\/\/doi.org\/10.1053\/j.gastro.2004.12.051","journal-title":"Gastroenterology"},{"key":"567_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102494","volume":"69","author":"IA Caspers","year":"2024","unstructured":"Caspers IA, Eikenboom EL, Lopez-Yurda M et al (2024) Gastric and duodenal cancer in individuals with Lynch syndrome: a nationwide cohort study. EClinicalMedicine 69:102494. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102494","journal-title":"EClinicalMedicine"},{"key":"567_CR7","doi-asserted-by":"publisher","first-page":"6877","DOI":"10.1245\/s10434-025-17664-4","volume":"32","author":"DC da Silva","year":"2025","unstructured":"da Silva DC, Sousa F, Silva A, Sousa-Pinto B (2025) Risk factors for gastric cancer in patients with Lynch syndrome: a systematic review and meta-analysis. Ann Surg Oncol 32:6877\u20136883","journal-title":"Ann Surg Oncol"},{"key":"567_CR8","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000739","author":"CF Lin","year":"2024","unstructured":"Lin CF, Carwana HE, Jiang SF, Li D (2024) Risk of gastric and small intestinal cancer in patients with Lynch syndrome\u2014data from a large, community-based U.S. population. Clin Transl Gastroenterol. https:\/\/doi.org\/10.14309\/ctg.0000000000000739","journal-title":"Clin Transl Gastroenterol"},{"key":"567_CR9","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/J.DLD.2025.09.025","volume":"57","author":"L Bujanda","year":"2025","unstructured":"Bujanda L, S\u00e1nchez A, Moreira L et al (2025) Pancreatic cancer and biliary tract tumors in individuals with Lynch syndrome. Dig Liver Dis 57:2464\u20132469. https:\/\/doi.org\/10.1016\/J.DLD.2025.09.025","journal-title":"Dig Liver Dis"},{"key":"567_CR10","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1001\/jama.2009.1529","volume":"302","author":"F Kastrinos","year":"2009","unstructured":"Kastrinos F, Mukherjee B, Tayob N (2009) Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302:1790\u20131795. https:\/\/doi.org\/10.1001\/jama.2009.1529","journal-title":"JAMA"},{"key":"567_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/J.ECLINM.2026.103755","volume":"91","author":"AM Bogdanski","year":"2026","unstructured":"Bogdanski AM, Klatte DCF, Bonsing BA et al (2026) Pancreatic cancer risk and survival in patients with Lynch syndrome: a nationwide Dutch cohort study. EClinicalMedicine 91:103755. https:\/\/doi.org\/10.1016\/J.ECLINM.2026.103755","journal-title":"EClinicalMedicine"},{"key":"567_CR12","unstructured":"Surveillance, epidemiology, and end results 21 program data, 2017\u20132019. https:\/\/seer.cancer.gov. Accessed 13 Mar 2026"},{"key":"567_CR13","unstructured":"Gupta S, Weiss JM, Burke CA, et al (2025) NCCN guidelines version 1.2025 genetic\/familial high-risk assessment: colorectal, endometrial, and gastric continue"},{"key":"567_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1053\/j.gastro.2009.10.051","volume":"138","author":"LG Capelle","year":"2010","unstructured":"Capelle LG, Van Grieken NCT, Lingsma HF et al (2010) Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in The Netherlands. Gastroenterology 138:487\u2013492. https:\/\/doi.org\/10.1053\/j.gastro.2009.10.051","journal-title":"Gastroenterology"},{"key":"567_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10689-021-00235-3","volume":"21","author":"CR Boland","year":"2022","unstructured":"Boland CR, Yurgelun MB, Mraz KA, Boland PM (2022) Managing gastric cancer risk in Lynch syndrome: controversies and recommendations. Fam Cancer 21:75\u201378","journal-title":"Fam Cancer"},{"key":"567_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1897-4287-11-9","volume":"11","author":"K Tutlewska","year":"2013","unstructured":"Tutlewska K, Lubinski J, Kurzawski G (2013) Germline deletions in the EPCAM gene as a cause of Lynch syndrome\u2014literature review. Hered Cancer Clin Pract 11:9. https:\/\/doi.org\/10.1186\/1897-4287-11-9","journal-title":"Hered Cancer Clin Pract"},{"key":"567_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14041000","author":"S Kumar","year":"2022","unstructured":"Kumar S, Farha N, Burke CA, Katona BW (2022) Upper gastrointestinal cancer surveillance in Lynch syndrome. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14041000","journal-title":"Cancers (Basel)"},{"key":"567_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/ijc.33294","volume":"148","author":"S Ladigan-Badura","year":"2021","unstructured":"Ladigan-Badura S, Vangala DB, Engel C et al (2021) Value of upper gastrointestinal endoscopy for gastric cancer surveillance in patients with Lynch syndrome. Int J Cancer 148:106\u2013114. https:\/\/doi.org\/10.1002\/ijc.33294","journal-title":"Int J Cancer"},{"key":"567_CR19","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1158\/1940-6207.CAPR-20-0269","volume":"13","author":"S Kumar","year":"2020","unstructured":"Kumar S, Dudzik CM, Reed M et al (2020) Upper endoscopic surveillance in Lynch syndrome detects gastric and duodenal adenocarcinomas. Cancer Prev Res 13:1047\u20131053. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-20-0269","journal-title":"Cancer Prev Res"},{"key":"567_CR20","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/ijc.33753","volume":"149","author":"DB Vangala","year":"2021","unstructured":"Vangala DB, Ladigan-Badura S, Engel C et al (2021) Early detection of duodenal cancer by upper gastrointestinal-endoscopy in Lynch syndrome. Int J Cancer 149:2052\u20132062. https:\/\/doi.org\/10.1002\/ijc.33753","journal-title":"Int J Cancer"},{"key":"567_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10120-020-01113-05","volume":"24","author":"H Cho","year":"2021","unstructured":"Cho H, Yamada M, Sekine S et al (2021) Gastric cancer is highly prevalent in Lynch syndrome patients with atrophic gastritis. Gastr Cancer 24:283\u2013291. https:\/\/doi.org\/10.1007\/s10120-020-01113-05","journal-title":"Gastr Cancer"},{"key":"567_CR22","first-page":"2994","volume":"6","author":"YJ Park","year":"2000","unstructured":"Park YJ, Shin K-H, Park J-G (2000) Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res 6:2994\u20132998","journal-title":"Clin Cancer Res"},{"key":"567_CR23","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/ags3.12809","volume":"8","author":"N Kanaya","year":"2024","unstructured":"Kanaya N, van Schaik TA, Aoki H et al (2024) High risk of multiple gastric cancers in Japanese individuals with Lynch syndrome. Ann Gastroenterol Surg 8:1008\u20131016. https:\/\/doi.org\/10.1002\/ags3.12809","journal-title":"Ann Gastroenterol Surg"},{"key":"567_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/CMR.00011-10","volume":"23","author":"LE Wroblewski","year":"2010","unstructured":"Wroblewski LE, Peek RM, Wilson KT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23:713\u2013739","journal-title":"Clin Microbiol Rev"},{"key":"567_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31\u201349","journal-title":"Acta Pathol Microbiol Scand"},{"key":"567_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","volume":"13","author":"P Correa","year":"2012","unstructured":"Correa P, Piazuelo MB (2012) The gastric precancerous cascade. J Dig Dis 13:2\u20139. https:\/\/doi.org\/10.1111\/j.1751-2980.2011.00550.x","journal-title":"J Dig Dis"},{"key":"567_CR27","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11523-024-01097-2","volume":"19","author":"LW Wu","year":"2024","unstructured":"Wu LW, Jang SJ, Shapiro C et al (2024) Diffuse gastric cancer: a comprehensive review of molecular features and emerging therapeutics. Target Oncol 19:845\u2013865","journal-title":"Target Oncol"},{"key":"567_CR28","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1158\/1055-9965.EPI-22-0210","volume":"31","author":"A Tavakkoli","year":"2022","unstructured":"Tavakkoli A, Pruitt SL, Hoang AQ et al (2022) Ethnic disparities in early-onset gastric cancer: a population-based study in Texas and California. Cancer Epidemiol Biomark Prev 31:1710. https:\/\/doi.org\/10.1158\/1055-9965.EPI-22-0210","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"567_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<551::AID-IJC13>3.0.CO;2-9","volume":"74","author":"M Aarnio","year":"1997","unstructured":"Aarnio M, Salovaara R, Aaltonen LA et al (1997) Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 74:551\u2013555. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19971021)74:5%26lt;551::AID-IJC13%26gt;3.0.CO;2-9","journal-title":"Int J Cancer"},{"key":"567_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00384-016-2524-7","volume":"31","author":"EC Soer","year":"2016","unstructured":"Soer EC, Leicher LW, Langers AMJ et al (2016) Equivalent Helicobacter pylori infection rates in Lynch syndrome mutation carriers with and without a first-degree relative with gastric cancer. Int J Colorectal Dis 31:693\u2013697. https:\/\/doi.org\/10.1007\/s00384-016-2524-7","journal-title":"Int J Colorectal Dis"},{"key":"567_CR31","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3390\/cancers","volume":"13","author":"R Chautard","year":"2021","unstructured":"Chautard R, Malka D, Samaha E et al (2021) Upper gastrointestinal lesions during endoscopy surveillance in patients with Lynch syndrome: a multicentre cohort study. Cancers (Basel) 13:1657. https:\/\/doi.org\/10.3390\/cancers","journal-title":"Cancers (Basel)"},{"key":"567_CR32","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.3390\/cancers","volume":"17","author":"V Disciglio","year":"2025","unstructured":"Disciglio V, Pardo C, Luzko I et al (2025) Academic editors: candida fasano familial non-hereditary gastric cancer: diagnosis, management. Mol Charact Future Perspect Cancers (Basel) 17:3209. https:\/\/doi.org\/10.3390\/cancers","journal-title":"Mol Charact Future Perspect Cancers (Basel)"},{"key":"567_CR33","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/PAS.0000000000000185","volume":"38","author":"SE Lee","year":"2014","unstructured":"Lee SE, Kang SY, Cho J et al (2014) Pyloric gland adenoma in Lynch syndrome. Am J Surg Pathol 38:784\u2013792. https:\/\/doi.org\/10.1097\/PAS.0000000000000185","journal-title":"Am J Surg Pathol"},{"key":"567_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy151.088","volume":"29","author":"M Fornasarig","year":"2018","unstructured":"Fornasarig M, Magris R, Maiero S et al (2018) Gastric cancer in Lynch syndrome: Are precancerous conditions co-risk factors? Ann Oncol 29:v24. https:\/\/doi.org\/10.1093\/annonc\/mdy151.088","journal-title":"Ann Oncol"},{"key":"567_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/J.GIE.2021.07.004","volume":"95","author":"N Farha","year":"2022","unstructured":"Farha N, Hrabe J, Sleiman J et al (2022) Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome. Gastrointest Endosc 95:105\u2013114. https:\/\/doi.org\/10.1016\/J.GIE.2021.07.004","journal-title":"Gastrointest Endosc"},{"key":"567_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"AJ Bass","year":"2014","unstructured":"Bass AJ, Thorsson V, Shmulevich I et al (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202\u2013209. https:\/\/doi.org\/10.1038\/nature13480","journal-title":"Nature"},{"key":"567_CR37","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.cgh.2019.07.012","volume":"18","author":"J Kim","year":"2020","unstructured":"Kim J, Braun D, Ukaegbu C et al (2020) Clinical factors associated with gastric cancer in individuals with Lynch syndrome. Clin Gastroenterol Hepatol 18:830-837.e1. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"567_CR38","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1055\/a-1016-4977","volume":"51","author":"ME van Leerdam","year":"2019","unstructured":"van Leerdam ME, Roos VH, van Hooft JE et al (2019) Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 51:1082\u20131093","journal-title":"Endoscopy"},{"key":"567_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ajg.2014.435","volume":"110","author":"S Syngal","year":"2015","unstructured":"Syngal S, Brand RE, Church JM et al (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110:223\u2013262. https:\/\/doi.org\/10.1038\/ajg.2014.435","journal-title":"Am J Gastroenterol"},{"key":"567_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/bjs.11902","volume":"108","author":"TT Sepp\u00e4l\u00e4","year":"2021","unstructured":"Sepp\u00e4l\u00e4 TT, Latchford A, Negoi I et al (2021) European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender. Br J Surg 108:484\u2013498","journal-title":"Br J Surg"},{"key":"567_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/jgh.16881","volume":"40","author":"N Abu-Freha","year":"2025","unstructured":"Abu-Freha N, Hozaeel W, Weissmann S et al (2025) Lynch Syndrome: similarities and differences of recommendations in published guidelines. J Gastroenterol Hepatol (Aust) 40:564\u2013573","journal-title":"J Gastroenterol Hepatol (Aust)"},{"key":"567_CR42","unstructured":"(2025) Deutsche Leitlinie Kolorektales Karzinom, Version 3.0"},{"key":"567_CR43","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","volume":"69","author":"KJ Monahan","year":"2020","unstructured":"Monahan KJ, Bradshaw N, Dolwani S et al (2020) Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI)\/United Kingdom Cancer Genetics Group (UKCGG). Gut 69:411\u2013444. https:\/\/doi.org\/10.1136\/gutjnl-2019-319915","journal-title":"Gut"},{"key":"567_CR44","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.gastha.2024.07.004","volume":"3","author":"E Gibson","year":"2024","unstructured":"Gibson E, Li H, Staub J et al (2024) Colonoscopy and upper endoscopy surveillance in Lynch syndrome: a longitudinal study from a large tertiary healthcare system. Gastroenterol Hepatol Adv 3:995\u20131000. https:\/\/doi.org\/10.1016\/j.gastha.2024.07.004","journal-title":"Gastroenterol Hepatol Adv"},{"key":"567_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/MCG.0000000000001799","volume":"57","author":"N Farha","year":"2023","unstructured":"Farha N, Kumar S, Katona BW et al (2023) The approach to performance of quality upper endoscopy in Lynch syndrome (QUELS): an international expert statement. J Clin Gastroenterol 57:31\u201338. https:\/\/doi.org\/10.1097\/MCG.0000000000001799","journal-title":"J Clin Gastroenterol"},{"key":"567_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2025.102025","author":"M Roma\u0144czyk","year":"2025","unstructured":"Roma\u0144czyk M, Feli\u0144ska Z, Januszewicz W (2025) How to measure quality in upper GI endoscopy. Best Pract Res Clin Gastroenterol. https:\/\/doi.org\/10.1016\/j.bpg.2025.102025","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"567_CR47","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.bpg.2013.09.005","volume":"27","author":"I Lansdorp-Vogelaar","year":"2013","unstructured":"Lansdorp-Vogelaar I, Sharp L (2013) Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Pract Res Clin Gastroenterol 27:933\u2013947","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"567_CR48","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/nejmoa2211807","volume":"388","author":"Y Usui","year":"2023","unstructured":"Usui Y, Taniyama Y, Endo M et al (2023) Helicobacter pylori, homologous-recombination genes, and gastric cancer. N Engl J Med 388:1181\u20131190. https:\/\/doi.org\/10.1056\/nejmoa2211807","journal-title":"N Engl J Med"},{"key":"567_CR49","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.6004\/jnccn.2019.0044","volume":"17","author":"S Gupta","year":"2019","unstructured":"Gupta S, Provenzale D, Llor X et al (2019) Genetic\/familial high-risk assessment: colorectal, version 2.2019 featured updates to the NCCN guidelines. JNCCN 17:1032\u20131041. https:\/\/doi.org\/10.6004\/jnccn.2019.0044","journal-title":"JNCCN"},{"key":"567_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3238\/arztebl.2013.0032","volume":"110","author":"V Steinke","year":"2013","unstructured":"Steinke V, Engel C, B\u00fcttner R et al (2013) Erblicher Darmkrebs ohne Polyposis. Dtsch Arztebl Int 110:32\u201338. https:\/\/doi.org\/10.3238\/arztebl.2013.0032","journal-title":"Dtsch Arztebl Int"},{"key":"567_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gii.2014.02.005","volume":"3","author":"M Song","year":"2014","unstructured":"Song M, Ang TL (2014) Early detection of early gastric cancer using image-enhanced endoscopy: current trends. Gastrointest Interv 3:1\u20137. https:\/\/doi.org\/10.1016\/j.gii.2014.02.005","journal-title":"Gastrointest Interv"},{"key":"567_CR52","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3748\/wjg.v25.i10.1248","volume":"25","author":"T Fujiyoshi","year":"2019","unstructured":"Fujiyoshi T, Miyahara R, Funasaka K et al (2019) Utility of linked color imaging for endoscopic diagnosis of early gastric cancer. World J Gastroenterol 25:1248\u20131258. https:\/\/doi.org\/10.3748\/wjg.v25.i10.1248","journal-title":"World J Gastroenterol"},{"key":"567_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/den.14455","volume":"35","author":"M Ishioka","year":"2023","unstructured":"Ishioka M, Osawa H, Hirasawa T et al (2023) Performance of an artificial intelligence-based diagnostic support tool for early gastric cancers: retrospective study. Dig Endosc 35:483\u2013491. https:\/\/doi.org\/10.1111\/den.14455","journal-title":"Dig Endosc"},{"key":"567_CR54","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.gastro.2025.01.253","volume":"169","author":"A Ebigbo","year":"2025","unstructured":"Ebigbo A, Messmann H, Lee SH (2025) Artificial intelligence applications in image-based diagnosis of early esophageal and gastric neoplasms. Gastroenterology 169:396-415.e2. https:\/\/doi.org\/10.1053\/j.gastro.2025.01.253","journal-title":"Gastroenterology"},{"key":"567_CR55","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1593\/neo.03505","volume":"6","author":"M Dinis-Ribeiro","year":"2004","unstructured":"Dinis-Ribeiro M, Da Costa-Pereira A, Lopes C et al (2004) Validity of serum pepsinogen I\/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia 6:449\u2013456. https:\/\/doi.org\/10.1593\/neo.03505","journal-title":"Neoplasia"},{"key":"567_CR56","doi-asserted-by":"publisher","first-page":"809","DOI":"10.5009\/gnl250055","volume":"19","author":"Y Choi","year":"2025","unstructured":"Choi Y, Kim N, Park JH et al (2025) Role of serum pepsinogen tests in detection of gastric atrophy, intestinal metaplasia, gastric adenoma, and gastric cancer in South Korea. Gut Liver 19:809\u2013820. https:\/\/doi.org\/10.5009\/gnl250055","journal-title":"Gut Liver"},{"key":"567_CR57","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2188\/jea.JE20150258","volume":"26","author":"F Ikeda","year":"2016","unstructured":"Ikeda F, Shikata K, Hata J et al (2016) Combination of Helicobacter pylori antibody and serum pepsinogen as a good predictive tool of gastric cancer incidence: 20-year prospective data from the Hisayama study. J Epidemiol 26:629\u2013636. https:\/\/doi.org\/10.2188\/jea.JE20150258","journal-title":"J Epidemiol"},{"key":"567_CR58","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1080\/00365521.2022.2068966","volume":"57","author":"L Faria","year":"2022","unstructured":"Faria L, Silva JC, Rodr\u00edguez-Carrasco M et al (2022) Gastric cancer screening: a systematic review and meta-analysis. Scand J Gastroenterol 57:1178\u20131188","journal-title":"Scand J Gastroenterol"},{"key":"567_CR59","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2020-322065","volume":"70","author":"JBY So","year":"2021","unstructured":"So JBY, Kapoor R, Zhu F et al (2021) Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population. Gut 70:829\u2013837. https:\/\/doi.org\/10.1136\/gutjnl-2020-322065","journal-title":"Gut"},{"key":"567_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/jamasurg.2014.1756","volume":"150","author":"CE Bailey","year":"2015","unstructured":"Bailey CE, Hu CY, You YN et al (2015) Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975\u20132010. JAMA Surg 150:17\u201322. https:\/\/doi.org\/10.1001\/jamasurg.2014.1756","journal-title":"JAMA Surg"},{"key":"567_CR61","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/J.DLD.2018.10.005","volume":"51","author":"N Hammoudi","year":"2019","unstructured":"Hammoudi N, Dhooge M, Coriat R et al (2019) Duodenal tumor risk in Lynch syndrome. Dig Liver Dis 51:299\u2013303. https:\/\/doi.org\/10.1016\/J.DLD.2018.10.005","journal-title":"Dig Liver Dis"},{"key":"567_CR62","doi-asserted-by":"publisher","first-page":"6378","DOI":"10.3390\/cancers13246378","volume":"13","author":"A S\u00e1nchez","year":"2021","unstructured":"S\u00e1nchez A, Bujanda L, Cuatrecasas M et al (2021) Identification of lynch syndrome carriers among patients with small bowel adenocarcinoma. Cancers (Basel) 13:6378. https:\/\/doi.org\/10.3390\/cancers13246378","journal-title":"Cancers (Basel)"},{"key":"567_CR63","doi-asserted-by":"crossref","unstructured":"Koornstra JJ, Kleibeuker JH, Vasen HFA (2008) Personal view small-bowel cancer in Lynch syndrome: is it time for surveillance?","DOI":"10.1016\/S1470-2045(08)70232-8"},{"key":"567_CR64","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.gie.2021.09.003","volume":"95","author":"A Jain","year":"2022","unstructured":"Jain A, Alimirah M, Stanich PP (2022) Upper GI tract screening in Lynch syndrome. Gastrointest Endosc 95:202. https:\/\/doi.org\/10.1016\/j.gie.2021.09.003","journal-title":"Gastrointest Endosc"},{"key":"567_CR65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/J.GIEC.2006.11.001","volume":"17","author":"KK Ho","year":"2007","unstructured":"Ho KK, Joyce AM (2007) Complications of capsule endoscopy. Gastrointest Endosc Clin N Am 17:169\u2013178. https:\/\/doi.org\/10.1016\/J.GIEC.2006.11.001","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"567_CR66","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.gie.2006.04.007","volume":"64","author":"AKH Chong","year":"2006","unstructured":"Chong AKH, Chin BWK, Meredith CG (2006) Clinically significant small-bowel pathology identified by double-balloon enteroscopy but missed by capsule endoscopy. Gastrointest Endosc 64:445\u2013449. https:\/\/doi.org\/10.1016\/j.gie.2006.04.007","journal-title":"Gastrointest Endosc"},{"key":"567_CR67","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/00365520701266898","volume":"42","author":"MM Baichi","year":"2007","unstructured":"Baichi MM, Arifuddin RM, Mantry PS (2007) Small-bowel masses found and missed on capsule endoscopy for obscure bleeding. Scand J Gastroenterol 42:1127\u20131132. https:\/\/doi.org\/10.1080\/00365520701266898","journal-title":"Scand J Gastroenterol"},{"key":"567_CR68","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820934314","author":"G Perrod","year":"2020","unstructured":"Perrod G, Samaha E, Perez-Cuadrado-Robles E et al (2020) Effectiveness of a dedicated small bowel neoplasia screening program by capsule endoscopy in Lynch syndrome: 5 years results from a tertiary care center. Therap Adv Gastroenterol. https:\/\/doi.org\/10.1177\/1756284820934314","journal-title":"Therap Adv Gastroenterol"},{"key":"567_CR69","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/J.DLD.2023.07.028","volume":"56","author":"P Cortegoso Valdivia","year":"2024","unstructured":"Cortegoso Valdivia P, Deding U, Bj\u00f8rsum-Meyer T et al (2024) Surveillance of the small-bowel by capsule endoscopy in Lynch syndrome\u2014a systematic review with meta-analysis. Dig Liver Dis 56:601\u2013606. https:\/\/doi.org\/10.1016\/J.DLD.2023.07.028","journal-title":"Dig Liver Dis"},{"key":"567_CR70","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1055\/S-0030-1255742\/ID\/6\/BIB","volume":"42","author":"JC Saurin","year":"2010","unstructured":"Saurin JC, Pilleul F, Soussan EB et al (2010) Small-bowel capsule endoscopy diagnoses early and advanced neoplasms in asymptomatic patients with Lynch syndrome. Endoscopy 42:1057\u20131062. https:\/\/doi.org\/10.1055\/S-0030-1255742\/ID\/6\/BIB","journal-title":"Endoscopy"},{"key":"567_CR71","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/S10689-014-9700-0","volume":"13","author":"P Urquhart","year":"2014","unstructured":"Urquhart P, Grimpen F, Lim GJ et al (2014) Capsule endoscopy versus magnetic resonance enterography for the detection of small bowel polyps in Peutz\u2013Jeghers syndrome. Fam Cancer 13:249\u2013255. https:\/\/doi.org\/10.1007\/S10689-014-9700-0","journal-title":"Fam Cancer"},{"key":"567_CR72","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1007\/S10620-011-1773-0\/TABLES\/5","volume":"56","author":"FA Hakim","year":"2011","unstructured":"Hakim FA, Alexander JA, Huprich JE et al (2011) CT-enterography may identify small bowel tumors not detected by capsule endoscopy: eight years experience at Mayo Clinic Rochester. Dig Dis Sci 56:2914\u20132919. https:\/\/doi.org\/10.1007\/S10620-011-1773-0\/TABLES\/5","journal-title":"Dig Dis Sci"},{"key":"567_CR73","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1055\/a-2199-7155","volume":"56","author":"MG Shiha","year":"2024","unstructured":"Shiha MG, Sidhu R, Lucaciu LA et al (2024) Device-assisted enteroscopy performance. Endoscopy 56:174\u2013181. https:\/\/doi.org\/10.1055\/a-2199-7155","journal-title":"Endoscopy"},{"key":"567_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/DIAGNOSTICS15070819","volume":"15","author":"E Borsotti","year":"2025","unstructured":"Borsotti E, Nava FL, Benedicenti F et al (2025) Hereditary colorectal cancer syndromes: small bowel cancer risk and endoscopic surveillance strategies. Diagnostics 15:15. https:\/\/doi.org\/10.3390\/DIAGNOSTICS15070819","journal-title":"Diagnostics"},{"key":"567_CR75","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.23.29812","volume":"222","author":"RX Liu","year":"2024","unstructured":"Liu RX, Li H, Towbin AJ et al (2024) Machine learning diagnosis of small-bowel Crohn disease using T2-weighted MRI radiomic and clinical data. AJR Am J Roentgenol 222:e2329812. https:\/\/doi.org\/10.2214\/AJR.23.29812","journal-title":"AJR Am J Roentgenol"},{"key":"567_CR76","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1148\/RADIOL.2021202363","volume":"299","author":"S Grosu","year":"2021","unstructured":"Grosu S, Wesp P, Graser A et al (2021) Machine learning-based differentiation of benign and premalignant colorectal polyps detected with CT colonography in an asymptomatic screening population: a proof-of-concept study. Radiology 299:326\u2013335. https:\/\/doi.org\/10.1148\/RADIOL.2021202363","journal-title":"Radiology"},{"key":"567_CR77","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1016\/S2589-7500(24)00048-7","volume":"6","author":"C Spada","year":"2024","unstructured":"Spada C, Piccirelli S, Hassan C et al (2024) AI-assisted capsule endoscopy reading in suspected small bowel bleeding: a multicentre prospective study. Lancet Digit Health 6:e345\u2013e353. https:\/\/doi.org\/10.1016\/S2589-7500(24)00048-7","journal-title":"Lancet Digit Health"},{"key":"567_CR78","doi-asserted-by":"publisher","first-page":"E970","DOI":"10.1055\/A-2161-1816","volume":"11","author":"FJ O\u2019Hara","year":"2023","unstructured":"O\u2019Hara FJ, Namara DM (2023) Capsule endoscopy with artificial intelligence-assisted technology: real-world usage of a validated AI model for capsule image review. Endosc Int Open 11:E970. https:\/\/doi.org\/10.1055\/A-2161-1816","journal-title":"Endosc Int Open"},{"key":"567_CR79","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/S41417-023-00721-Z","volume":"31","author":"M Boeri","year":"2024","unstructured":"Boeri M, Signoroni S, Ciniselli CM et al (2024) Detection of (pre)cancerous colorectal lesions in Lynch syndrome patients by microsatellite instability liquid biopsy. Cancer Gene Ther 31:842. https:\/\/doi.org\/10.1038\/S41417-023-00721-Z","journal-title":"Cancer Gene Ther"},{"key":"567_CR80","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1158\/1940-6207.CAPR-23-0107","volume":"16","author":"RM Bramblet","year":"2023","unstructured":"Bramblet RM, Bakkum-Gamez JN, Slettedahl SW et al (2023) Methylated DNA markers for sporadic colorectal and endometrial cancer are strongly associated with Lynch syndrome cancers. Cancer Prev Res (Phila) 16:611. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-23-0107","journal-title":"Cancer Prev Res (Phila)"},{"key":"567_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/J.BPG.2025.101974","volume":"74","author":"AM Bogdanski","year":"2025","unstructured":"Bogdanski AM, Acedo P, Wallace MB et al (2025) Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals. Best Pract Res Clin Gastroenterol 74:101974. https:\/\/doi.org\/10.1016\/J.BPG.2025.101974","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"567_CR82","unstructured":"Society AC (2025) Pancreatic neuroendocrine tumor (NET). Available from: https:\/\/www.cancer.org\/cancer\/types\/pancreatic-neuroendocrine-tumor.html"},{"key":"567_CR83","unstructured":"Puckett Y, Garfield K (2024) Pancreatic cancer. StatPearls"},{"key":"567_CR84","unstructured":"Guidelines N (2025) Pancreatic adenocarcinoma. Available from: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1455"},{"key":"567_CR85","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1055\/A-0965-0605","volume":"51","author":"ME Van Leerdam","year":"2019","unstructured":"Van Leerdam ME, Roos VH, Van Hooft JE et al (2019) Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 51:877\u2013895. https:\/\/doi.org\/10.1055\/A-0965-0605","journal-title":"Endoscopy"},{"key":"567_CR86","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1053\/J.GASTRO.2005.11.032","volume":"130","author":"AE De Jong","year":"2006","unstructured":"De Jong AE, Hendriks YMC, Kleibeuker JH et al (2006) Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 130:665\u2013671. https:\/\/doi.org\/10.1053\/J.GASTRO.2005.11.032","journal-title":"Gastroenterology"},{"key":"567_CR87","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/GUTJNL-2019-319352","volume":"69","author":"M Goggins","year":"2020","unstructured":"Goggins M, Overbeek KA, Brand R et al (2020) Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut 69:7\u201317. https:\/\/doi.org\/10.1136\/GUTJNL-2019-319352","journal-title":"Gut"},{"key":"567_CR88","unstructured":"InSiGHT (2018) Lynch syndrome. Available from: https:\/\/www.insight-group.org\/syndromes\/lynch-syndrome"},{"key":"567_CR89","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/S10689-024-00368-1","volume":"23","author":"AM Bogdanski","year":"2024","unstructured":"Bogdanski AM, van Hooft JE, Boekestijn B et al (2024) Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. Fam Cancer 23:323\u2013339. https:\/\/doi.org\/10.1007\/S10689-024-00368-1","journal-title":"Fam Cancer"},{"key":"567_CR90","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00298","author":"M Dbouk","year":"2022","unstructured":"Dbouk M, Katona BW, Brand RE et al (2022) The multicenter cancer of pancreas screening study: impact on stage and survival. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.22.00298","journal-title":"J Clin Oncol"},{"key":"567_CR91","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/JAMAONCOL.2024.1930","volume":"10","author":"AL Blackford","year":"2024","unstructured":"Blackford AL, Canto MI, Dbouk M et al (2024) Pancreatic cancer surveillance and survival of high-risk individuals. JAMA Oncol 10:1087\u20131096. https:\/\/doi.org\/10.1001\/JAMAONCOL.2024.1930","journal-title":"JAMA Oncol"},{"key":"567_CR92","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1053\/J.GASTRO.2023.02.032","volume":"164","author":"DCF Klatte","year":"2023","unstructured":"Klatte DCF, Boekestijn B, Onnekink AM et al (2023) Surveillance for pancreatic cancer in high-risk individuals leads to improved outcomes: a propensity score-matched analysis. Gastroenterology 164:1223-1231.e4. https:\/\/doi.org\/10.1053\/J.GASTRO.2023.02.032","journal-title":"Gastroenterology"},{"key":"567_CR93","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/S10689-024-00392-1","volume":"23","author":"L Wang","year":"2024","unstructured":"Wang L, Levinson R, Mezzacappa C, Katona BW (2024) Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer. Fam Cancer 23:351. https:\/\/doi.org\/10.1007\/S10689-024-00392-1","journal-title":"Fam Cancer"},{"key":"567_CR94","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1200\/JCO.22.00194","volume":"40","author":"DCF Klatte","year":"2022","unstructured":"Klatte DCF, Boekestijn B, Wasser MNJM et al (2022) Pancreatic cancer surveillance in carriers of a germline CDKN2A Pathogenic variant: yield and outcomes of a 20-year prospective follow-up. J Clin Oncol 40:3267\u20133277. https:\/\/doi.org\/10.1200\/JCO.22.00194","journal-title":"J Clin Oncol"},{"key":"567_CR95","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/UEG2.12422","volume":"11","author":"IJM Levink","year":"2023","unstructured":"Levink IJM, Jaarsma SC, Koopmann BDM et al (2023) The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program. United Eur Gastroenterol J 11:601\u2013611. https:\/\/doi.org\/10.1002\/UEG2.12422","journal-title":"United Eur Gastroenterol J"},{"key":"567_CR96","doi-asserted-by":"publisher","DOI":"10.1053\/J.GASTRO.2025.08.034","author":"AL Lucas","year":"2025","unstructured":"Lucas AL, Simeone DM, Katona BW et al (2025) Validation of a serum-based biomarker signature for detection of early-stage pancreatic ductal adenocarcinoma. Gastroenterology. https:\/\/doi.org\/10.1053\/J.GASTRO.2025.08.034","journal-title":"Gastroenterology"},{"key":"567_CR97","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/UEG2.12723","volume":"13","author":"N Podin\u0103","year":"2025","unstructured":"Podin\u0103 N, Gheorghe EC, Constantin A et al (2025) Artificial intelligence in pancreatic imaging: a systematic review. United Eur Gastroenterol J 13:55\u201377. https:\/\/doi.org\/10.1002\/UEG2.12723","journal-title":"United Eur Gastroenterol J"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00567-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00567-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00567-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:17:02Z","timestamp":1778480222000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00567-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":97,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00567-y","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.H.: Research: Deutsche Krebshilfe, Wilhelm-Sander-Stiftung; Speaker: MSD, Fujifilm Europe; Other: Endoscopic equipment on loan by Fujifilm. The other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"52"}}